Entity Type
Company
Filer Snapshot
MapLight Therapeutics, Inc. SEC EDGAR Filings
SEC filings, ownership reports, and insider transactions for CIK 0001770069.
Total Filings
136
Latest Filing
06 May 2026
Industry
Pharmaceutical Preparations
Save this filer page for the next filing cycle
Keep this page in your research queue, then return to compare new filings with prior context.
Save and revisit
Save this filer page
Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.
Best next steps
Start with the latest filings table, then open the strongest context page for this filer.
- Use the filings table to verify the newest submission, form type, and report period.
- Open the deeper context page only when this filer actually has insider or ownership signal.
Source: SEC Forms 3/4/5
View Source Filing
4 filed on 06 May 2026 for CIK 0001770069.
- Symbol
- MPLT on Nasdaq
- Business address
- 800 Chesapeake Drive, Redwood City, CA, 94063
- State of incorporation
- DE
- Fiscal year end
- 31 December
- Former names
- Alvarado Therapeutics, Inc. (to 22 Mar 2019)
Quick Takeaways
- MapLight Therapeutics, Inc. is an SEC filer tracked under CIK 0001770069.
- 136 filings are listed on this profile.
- Common form coverage includes 4, 144, 8-K and more.
What Changed
- Latest filing: 4 filed on 06 May 2026.
- Report period: 04 May 2026.
Why This Matters
- You can quote filing dates and form types directly from the SEC record on this page.
- Use this profile before deeper ownership or insider analysis to confirm filing history context.
Source Evidence
Source: SEC Forms 3/4/5
View Source Filing
4 filed on 06 May 2026 for CIK 0001770069.
Return Loop
Why revisit this filer page
A newly filed 4 can change the filing history, ownership context, or next research path for MapLight Therapeutics, Inc..
- Latest source-backed update
- 4 filed 06 May 2026
- Why come back
- Revisit after a new SEC filing appears to compare the updated record with prior filings.
- Latest filing on record: 4 filed 06 May 2026.
- Save this filer if you want a stable place to return after the next filing cycle.
- Open the latest filing table or ownership context to verify what changed.
Filer freshness comes from SEC EDGAR submission history and related source-backed ownership or portfolio filings when available.
Latest update
What changed recently for MapLight Therapeutics, Inc.
Latest financial period: Q4 2025. Open the source-backed page to inspect the fresh filing or facts context.
Update date
26 Mar 2026
Page type
Company facts
Latest period
Q4 2025
SEC-backed company facts were refreshed from filings filed on 26 Mar 2026.
Benchmark Context
Benchmark context for this company
MapLight Therapeutics, Inc. has a source-backed company facts view where you can compare the latest reported metrics with its own recent history and with peer rankings for the same metric.
Compared with
Start on the facts page for period-to-period context, then open a metric ranking when you want to compare the same reported fact across other SEC-reporting companies.
Why this is notable
Latest financial period: Q4 2025. That gives you a fresh baseline before you compare this company with peers.
- Latest company facts filing date: 26 Mar 2026.
- Peer comparisons stay conservative: same metric, compatible units, latest valid company row only.
- Open the facts page first if you want the cleanest path to verification.
Benchmark context is only shown where the app has enough comparable SEC-backed data to keep the interpretation honest.
Company intelligence
Research MapLight Therapeutics, Inc. from filings to ownership signals
Use this company page as the hub for SEC filings, fundamentals, insider activity, large-stake holders, and institutional ownership context.
Active modules
3/5
Available company intelligence paths on this page.
Filings
136
SEC submissions provide the evidence trail.
Ownership context
1/3
Insider, large-stake, and institutional ownership lanes.
Return loop
Watch
Save the company so the next source-backed change has a clear place to bring you back.
Best-of company intelligence workflow
What changed?
Start with the latest filing and active ownership modules before opening older table rows.
Why might it matter?
Use insider, 13D/G, and 13F context to separate routine filings from ownership signals.
Where is evidence?
Keep SEC source documents one click away through filings, facts, insider reports, and Schedule 13D/G records.
What to watch next?
Save the company so watchlists can bring you back when the next filing-backed update lands.
SEC-verifiable company research path
Every company hub should answer what changed, why ownership activity might matter, where SEC evidence lives, and which filer, insider, holder, or filing page deserves the next click.
SEC filings
AvailableLatest company filings
Start with the filing timeline to verify the newest source document and report period.
Company facts
AvailableFinancial context
Use XBRL facts when ownership activity needs revenue, earnings, debt, or cash-flow context.
Forms 3/4/5
AvailableInsider activity
Check whether directors, officers, or 10% owners are buying, selling, or filing fresh ownership changes.
Schedule 13D/G
ExploreLarge-stake holders
Review beneficial ownership filings for activist-style or passive large holder changes around this issuer.
Form 13F
ExploreInstitutional holders
Compare manager filings and smart-money context when company-level ownership needs broader holders.
SEC-verifiable company hub
The strongest research path is the one that keeps source documents close: filings first, then ownership signals, insider context, and fundamentals.
Watchlist return triggers
Watch MapLight Therapeutics, Inc. when any filing-backed ownership signal appears, then jump back into the exact SEC evidence path.
new company filing
insider Form 4
13D/G holder change
13F holder update
Filer Overview
MapLight Therapeutics, Inc. has filed 136 SEC EDGAR filings since 08 Mar 2019. Common forms include 4, 144, 8-K, ARS and more.
Latest Filings
Recent SEC filings for MapLight Therapeutics, Inc. with direct links to document and filing folders.
About this filer
MapLight Therapeutics, Inc. files with the SEC under CIK 0001770069. This page aggregates EDGAR filings and related ownership activity.
Industry: Pharmaceutical Preparations.
FAQ
- What is a CIK?
- A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
- Why are some filings missing?
- New filings appear as the SEC updates EDGAR, and older records can vary by availability.
- How often is this page updated?
- Updates follow new EDGAR submissions and periodic data refreshes.